Wilson-Thompson Kathleen

SEC source: 0001771340-20-000009 · edgardoc.xml · nonDerivative · entry 2

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,042

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020.

SEC source: 0001771340-20-000009 · edgardoc.xml · nonDerivative · entry 1

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,300

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020.

SEC source: 0001618921-20-000071 · wf-form4_159908740022424.xml · nonDerivative · entry 1

Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,818

F1 · kind: Disposition relating to the satisfaction of tax withholding obligations upon the settlement of restricted stock unit award granted in accordance with Rule 16b-3.

F2 · balance_after: Includes shares underlying restricted stock units issued in lieu of dividends (through August 31, 2020) on outstanding restricted stock units.

SEC source: 0001771364-20-000017 · edgardoc.xml · derivative · entry 17

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,000

Underlying: Common Stock · 12,500 shares

Expires 2026-06-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020, as adjusted to give effect to a five-for-one forward split of the Issuer's common stock in the form of a stock dividend distributed on August 28, 2020.

F16 · derivative.exercise_date: 1/36th of the shares granted shall become vested and exercisable as of each monthly anniversary of the grant date beginning on July 18, 2019, such that all shares subject to the Option shall be fully vested and exercisable by June 18, 2022.

SEC source: 0001771364-20-000017 · edgardoc.xml · nonDerivative · entry 16

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,800

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020, as adjusted to give effect to a five-for-one forward split of the Issuer's common stock in the form of a stock dividend distributed on August 28, 2020.

F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $459.350 to $459.800, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001771364-20-000017 · edgardoc.xml · nonDerivative · entry 15

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,480

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020, as adjusted to give effect to a five-for-one forward split of the Issuer's common stock in the form of a stock dividend distributed on August 28, 2020.

F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $458.000 to $458.990, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001771364-20-000017 · edgardoc.xml · nonDerivative · entry 14

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,193

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020, as adjusted to give effect to a five-for-one forward split of the Issuer's common stock in the form of a stock dividend distributed on August 28, 2020.

F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $456.930 to $457.860, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001771364-20-000017 · edgardoc.xml · nonDerivative · entry 13

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,893

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020, as adjusted to give effect to a five-for-one forward split of the Issuer's common stock in the form of a stock dividend distributed on August 28, 2020.

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $455.720 to $456.690, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001771364-20-000017 · edgardoc.xml · nonDerivative · entry 12

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,553

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020, as adjusted to give effect to a five-for-one forward split of the Issuer's common stock in the form of a stock dividend distributed on August 28, 2020.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $454.720 to $455.690, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001771364-20-000017 · edgardoc.xml · nonDerivative · entry 11

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,847

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020, as adjusted to give effect to a five-for-one forward split of the Issuer's common stock in the form of a stock dividend distributed on August 28, 2020.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $453.480 to $453.990, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001771364-20-000017 · edgardoc.xml · nonDerivative · entry 10

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,047

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020, as adjusted to give effect to a five-for-one forward split of the Issuer's common stock in the form of a stock dividend distributed on August 28, 2020.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $451.850 to $452.6600, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001771364-20-000017 · edgardoc.xml · nonDerivative · entry 9

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,447

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020, as adjusted to give effect to a five-for-one forward split of the Issuer's common stock in the form of a stock dividend distributed on August 28, 2020.

SEC source: 0001771364-20-000017 · edgardoc.xml · nonDerivative · entry 8

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,547

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020, as adjusted to give effect to a five-for-one forward split of the Issuer's common stock in the form of a stock dividend distributed on August 28, 2020.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $448.780 to $449.440, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001771364-20-000017 · edgardoc.xml · nonDerivative · entry 7

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020, as adjusted to give effect to a five-for-one forward split of the Issuer's common stock in the form of a stock dividend distributed on August 28, 2020.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $447.750 to $448.600, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001771364-20-000017 · edgardoc.xml · nonDerivative · entry 6

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,650

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020, as adjusted to give effect to a five-for-one forward split of the Issuer's common stock in the form of a stock dividend distributed on August 28, 2020.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $446.640 to $447.600, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001771364-20-000017 · edgardoc.xml · nonDerivative · entry 5

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,533

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020, as adjusted to give effect to a five-for-one forward split of the Issuer's common stock in the form of a stock dividend distributed on August 28, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $445.220 to $446.190, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001771364-20-000017 · edgardoc.xml · nonDerivative · entry 4

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,925

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020, as adjusted to give effect to a five-for-one forward split of the Issuer's common stock in the form of a stock dividend distributed on August 28, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $440.070 to $445.000, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001771364-20-000017 · edgardoc.xml · nonDerivative · entry 3

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,600

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020, as adjusted to give effect to a five-for-one forward split of the Issuer's common stock in the form of a stock dividend distributed on August 28, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $443.060 to $444.000, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001771364-20-000017 · edgardoc.xml · nonDerivative · entry 2

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,000

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020, as adjusted to give effect to a five-for-one forward split of the Issuer's common stock in the form of a stock dividend distributed on August 28, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $441.900 to $442.790, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001771364-20-000017 · edgardoc.xml · nonDerivative · entry 1

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,300

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020, as adjusted to give effect to a five-for-one forward split of the Issuer's common stock in the form of a stock dividend distributed on August 28, 2020.

SEC source: 0001771364-20-000014 · edgardoc.xml · derivative · entry 3

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,500

Underlying: Common Stock · 2,500 shares

Expires 2026-06-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020.

F2 · derivative.exercise_date: 1/36th of the shares granted shall become vested and exercisable as of each monthly anniversary of the grant date beginning on July 18, 2019, such that all shares subject to the Option shall be fully vested and exercisable by June 18, 2022.

SEC source: 0001771364-20-000014 · edgardoc.xml · nonDerivative · entry 2

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 360

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020.

SEC source: 0001771364-20-000014 · edgardoc.xml · nonDerivative · entry 1

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,860

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020.

SEC source: 0001127602-20-003166 · form4.xml · derivative · entry 1

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,225

Underlying: Common Stock · 1,449 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock.

F2 · derivative.exercise_date: Grant of stock-settled Restricted Stock Units granted under Ashland's Omnibus Incentive Plan and deferred under Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.)

F2 · derivative.expiration_date: Grant of stock-settled Restricted Stock Units granted under Ashland's Omnibus Incentive Plan and deferred under Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.)

F3 · balance_after: Balance includes 12 additional Restricted Stock Units acquired in lieu of cash dividends paid on March 15, 2019, 13 additional Restricted Stock Units acquired in lieu of cash dividends paid on June 15, 2019, 13 additional Restricted Stock Units acquired in lieu of cash dividends paid on September 15, 2019, and 14 additional Restricted Stock Units acquired in lieu of cash dividends paid on December 15, 2019.

SEC source: 0001618921-19-000120 · edgar.xml · nonDerivative · entry 1

Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,147

F1 · kind: This is a grant of restricted stock units under the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan (together with the related award agreement and the applicable election forms thereunder, the "Plan"). The shares underlying these restricted stock units vest with respect to 5,778 shares on September 1, 2020 and with respect to 5,778 shares on September 1, 2021, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan.

F2 · balance_after: Includes shares underlying restricted stock units issued in lieu of dividends (through November 30, 2019) on outstanding restricted stock units.

SEC source: 0001618921-19-000110 · edgar.xml · derivative · entry 3

Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,359

Underlying: Common Stock · 54,359 shares

Expires 2029-11-01

F2 · derivative.exercise_date: The option vests with respect to 18,102 shares on November 1, 2020, with respect to 18,102 shares on November 1, 2021, and with respect to 18,155 shares on November 1, 2022, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan.

SEC source: 0001618921-19-000110 · edgar.xml · nonDerivative · entry 1

Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,462

F1 · kind: This is a grant of restricted stock units under the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan (together with the related award agreement and the applicable election forms thereunder, the "Plan"). The shares underlying these restricted stock units vest with respect to 2,868 shares on November 1, 2020, with respect to 2,868 shares on November 1, 2021, and with respect to 2,878 shares on November 1, 2022, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan.

SEC source: 0001618921-19-000078 · edgar.xml · nonDerivative · entry 2

Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,848

F2 · kind: Disposition relating to the satisfaction of tax withholding obligations upon the settlement of award granted in accordance with Rule 16b-3.

F3 · balance_after: Includes: (i) 250 underlying restricted stock units issued in lieu of dividends (through September 30, 2019) on outstanding restricted stock units; and (ii) with respect to shares purchased under the WBA employee stock purchase plan, 81 shares on November 30, 2018, 101 shares on December 31, 2018, 95 shares on January 31, 2019, 97 shares on February 28, 2019, 109 shares on March 29, 2019 and 68 shares on April 30, 2019.

SEC source: 0001618921-19-000078 · edgar.xml · nonDerivative · entry 1

Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,318

F1 · kind: Shares issued upon settlement of performance share award (not a derivative security within the meaning of Rule 16a-1(c)) granted on November 1, 2016 under the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended.

F3 · balance_after: Includes: (i) 250 underlying restricted stock units issued in lieu of dividends (through September 30, 2019) on outstanding restricted stock units; and (ii) with respect to shares purchased under the WBA employee stock purchase plan, 81 shares on November 30, 2018, 101 shares on December 31, 2018, 95 shares on January 31, 2019, 97 shares on February 28, 2019, 109 shares on March 29, 2019 and 68 shares on April 30, 2019.

SEC source: 0001771340-19-000006 · edgardoc.xml · nonDerivative · entry 1

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 360

F1 · kind: The transaction reported on this Form 4 is an open market purchase of Tesla Common Stock on August 14, 2019.

SEC source: 0001771340-19-000010 · edgardoc.xml · derivative · entry 1

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2026-06-18

F1 · derivative.exercise_date: This stock option is a triennial equity award that was automatically granted pursuant to the Issuer's Outside Director Compensation Policy as described in its proxy statement. 1/36th of the shares granted shall become vested and exercisable as of each monthly anniversary of the grant date beginning on July 18, 2019, such that all shares subject to the Option shall be fully vested and exercisable by June 18, 2022.

SEC source: 0001771364-19-000003 · edgardoc.xml · derivative · entry 2

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 9,000 shares

Expires 2026-04-29

F1 · derivative.exercise_date: This stock option award is an automatic triennial equity award granted pursuant to the Company's 2010 Equity Incentive Plan and Outside Director Compensation Policy. 1/36th of the shares granted shall become vested and exercisable as of each monthly anniversary from April 29, 2019, such that all shares subject to the Option shall be fully vested and exercisable by April 29, 2022.

SEC source: 0001771364-19-000003 · edgardoc.xml · derivative · entry 1

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 6,000 shares

Expires 2026-04-29

F1 · derivative.exercise_date: This stock option award is an automatic triennial equity award granted pursuant to the Company's 2010 Equity Incentive Plan and Outside Director Compensation Policy. 1/36th of the shares granted shall become vested and exercisable as of each monthly anniversary from April 29, 2019, such that all shares subject to the Option shall be fully vested and exercisable by April 29, 2022.

SEC source: 0001127602-19-005337 · form4.xml · derivative · entry 1

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,723

Underlying: Common Stock · 1,413 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock.

F2 · derivative.exercise_date: Grant of deferred Restricted Stock Units pursuant to Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.)

F2 · derivative.expiration_date: Grant of deferred Restricted Stock Units pursuant to Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.)

F3 · balance_after: Balance includes 7 additional Restricted Stock Units acquired in lieu of cash dividends paid on March 15, 2018, 7 additional Restricted Stock Units acquired in lieu of cash dividends paid on June 15, 2018, 7 additional Restricted Stock Units acquired in lieu of cash dividends paid on September 15, 2018 and 8 additional Restricted Stock Units acquired in lieu of cash dividends paid on December 15, 2018, pursuant to Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3.

SEC source: 0001494732-19-000005 · edgardoc.xml · derivative · entry 1

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,334

Underlying: Common Stock · 8,334 shares

Expires 2026-01-07

F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest and become exercisable on June 18, 2019. Pursuant to the issuer's Outside Director Compensation Policy, this equity award was granted to the reporting person in connection with her appointment to the issuer's Board of Directors.

SEC source: 0001618921-18-000084 · edgar.xml · derivative · entry 5

Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,444

Underlying: Common Stock · 44,444 shares

Expires 2028-11-01

F4 · derivative.exercise_date: The option vests with respect to 14,800 shares on November 1, 2019, with respect to 14,800 shares on November 1, 2020, and with respect to 14,844 shares on November 1, 2021, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan (together with the related agreement thereunder).

SEC source: 0001618921-19-000053 · edgar.xml · derivative · entry 1

Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,110

Underlying: Common Stock · 51,110 shares

Expires 2028-11-01

F1 · shares: This amended report on Form 4 is being filed solely to correct the number of options granted to the reporting person on November 1, 2018 and to update the related vesting schedule, which was reported incorrectly in the original report on Form 4 due to an administrative error. This amendment corrects the total number of options granted to the reporting person from 44,444 to 51,110.

F2 · derivative.exercise_date: The option vests with respect to 17,019 shares on November 1, 2019, with respect to 17,020 shares on November 1, 2020, and with respect to 17,071 shares on November 1, 2021, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan (together with the related agreement thereunder).

SEC source: 0001618921-18-000084 · edgar.xml · nonDerivative · entry 3

Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,676

F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.66 to $78.58, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or any securityholder of the issuer, upon request, information regarding the number of shares sold at each price within the range indicated.

SEC source: 0001618921-18-000084 · edgar.xml · nonDerivative · entry 2

Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,076

F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

SEC source: 0001618921-18-000084 · edgar.xml · nonDerivative · entry 1

Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,076

F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.04 to $78.96, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or any securityholder of the issuer, upon request, information regarding the number of shares sold at each price within the range indicated.

SEC source: 0001618921-18-000059 · edgar.xml · nonDerivative · entry 2

Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,676

F2 · kind: Disposition relating to the satisfaction of tax withholding obligations upon the settlement of award granted in accordance with Rule 16b-3.

SEC source: 0001618921-18-000059 · edgar.xml · nonDerivative · entry 1

Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,201

F1 · kind: Shares issued upon settlement of peformance share award (not a derivative security within the meaning of Rule 16a-1(c)) granted on November 1, 2015 under the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended.

SEC source: 0001618921-18-000039 · edgar.xml · nonDerivative · entry 1

Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,558

F1 · balance_after: Includes shares underlying restricted stock units issued in lieu of dividends (through July 31, 2018) on outstanding restricted stock units.

SEC source: 0001562180-18-002480 · primarydocument.xml · derivative · entry 1

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,780.89

Underlying: Common Stock · 1,180 shares

Expires not disclosed

F1 · derivative.exercise_price: Convertible on a 1-for-1 basis.

F2 · kind: Annual deferred stock grant made to the reporting person under the Vulcan Materials Company 2016 Omnibus Long-Term Incentive Plan.

F3 · price: Deferred Stock Units are fully vested as of the grant date. Vested shares will be delivered to the reporting person in the month of April following the year in which the reporting person ceases to be a member of the Board of Directors, unless the reporting person has elected to defer payment of the award, or unless payment is made earlier due to the death or disability of the reporting person or a change in control of Vulcan.

F3 · derivative.exercise_date: Deferred Stock Units are fully vested as of the grant date. Vested shares will be delivered to the reporting person in the month of April following the year in which the reporting person ceases to be a member of the Board of Directors, unless the reporting person has elected to defer payment of the award, or unless payment is made earlier due to the death or disability of the reporting person or a change in control of Vulcan.

F3 · derivative.expiration_date: Deferred Stock Units are fully vested as of the grant date. Vested shares will be delivered to the reporting person in the month of April following the year in which the reporting person ceases to be a member of the Board of Directors, unless the reporting person has elected to defer payment of the award, or unless payment is made earlier due to the death or disability of the reporting person or a change in control of Vulcan.

SEC source: 0001127602-18-002682 · form4.xml · derivative · entry 1

Wilson-Thompson Kathleen · CIK 0001331680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,281

Underlying: Common Stock · 1,453 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock.

F2 · derivative.exercise_date: Grant of deferred Restricted Stock Units pursuant to Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.)

F2 · derivative.expiration_date: Grant of deferred Restricted Stock Units pursuant to Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.)

F3 · balance_after: Balance includes 2 additional Restricted Stock Units acquired in lieu of cash dividends on December 15, 2017, pursuant to Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3.

SEC source: 0001618921-17-000088 · edgar.xml · derivative · entry 3

Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,649

Underlying: Common Stock · 69,649 shares

Expires 2027-11-01

F3 · derivative.exercise_date: The option vests with respect to 23,193 shares on November 1, 2018, with respect to 23,193 shares on November 1, 2019, and with respect to 23,263 shares on November 1, 2020, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended (together with the related agreement thereunder).

SEC source: 0001618921-17-000088 · edgar.xml · nonDerivative · entry 1

Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,009

F1 · kind: Disposition relating to the satisfaction of tax withholding obligations upon the settlement of restricted stock unit award granted in accordance with Rule 16b-3.

F2 · balance_after: Includes shares underlying restricted stock units issued in lieu of dividends (through September 30, 2017) on outstanding restricted stock units.

SEC source: 0001618921-17-000076 · edgar.xml · nonDerivative · entry 2

Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,202

F2 · kind: Disposition relating to the satisfaction of tax withholding obligations upon the settlement of award granted in accordance with Rule 16b-3.

F3 · balance_after: Includes shares underlying restricted stock units issued in lieu of dividends (through September 30, 2017) on outstanding restricted stock units.

SEC source: 0001618921-17-000076 · edgar.xml · nonDerivative · entry 1

Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,335

F1 · kind: Shares issued upon settlement of peformance share award (not a derivative security within the meaning of Rule 16a-1(c)) granted on November 1, 2014 under the 2013 Omnibus Incentive Plan, as amended.

F3 · balance_after: Includes shares underlying restricted stock units issued in lieu of dividends (through September 30, 2017) on outstanding restricted stock units.

SEC source: 0001618921-17-000060 · edgar.xml · nonDerivative · entry 1

Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,562

F1 · balance_after: Includes shares underlying restricted stock units issued in lieu of dividends (through July 31, 2017) on outstanding restricted stock units.